Company Filing History:
Years Active: 1995-2003
Title: Halldor Thormar: Innovator in Therapeutic Formulations
Introduction
Halldor Thormar is a notable inventor based in Reykjavik, Iceland. He has made significant contributions to the field of therapeutic formulations, particularly in the treatment of mucosal infections. With a total of 3 patents to his name, Thormar's work has the potential to impact various medical applications.
Latest Patents
Thormar's latest patents include innovative formulations aimed at treating infections caused by bacteria, fungi, or viruses, such as Herpes Simplex Virus. His method involves topically administering a formulation that contains at least one microbicidal lipid, a solubilizing agent, and optionally a gel-forming agent. This formulation can be in the form of a hydrogel, utilizing fatty acids like lauric acid or monoglycerides for effective treatment. Another significant patent focuses on a process for disinfecting contact lenses using a mixture solution of antimicrobial fatty acids or their derivatives.
Career Highlights
Throughout his career, Halldor Thormar has worked with various companies, including Lipomedica Ehf. His expertise in the field has led to the development of novel pharmaceutical formulations that enhance the effectiveness of treatments for mucosal infections.
Collaborations
Thormar has collaborated with notable professionals in his field, including Charles E. Isaacs and Kwang S. Kim. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Halldor Thormar's innovative work in therapeutic formulations showcases his dedication to improving medical treatments for infections. His contributions are significant in the realm of pharmaceutical science, and his patents reflect a commitment to advancing healthcare solutions.